Alexion Eyes European Headquarters in Zurich on Expansion Push

Alexion Pharmaceuticals Inc., an American biopharmaceutical company, said it is examining a move of its European headquarters to Zurich from Lausanne in a push to expand its Swiss operations.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.